{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:16:10Z","timestamp":1790129770739,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000521","name":"Canadian Cancer Society","doi-asserted-by":"publisher","award":["706396"],"award-info":[{"award-number":["706396"]}],"id":[{"id":"10.13039\/501100000521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["429161"],"award-info":[{"award-number":["429161"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["427647"],"award-info":[{"award-number":["427647"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","award":["RT-2020-0630"],"award-info":[{"award-number":["RT-2020-0630"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DE170100575"],"award-info":[{"award-number":["DE170100575"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["170102471"],"award-info":[{"award-number":["170102471"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1117017"],"award-info":[{"award-number":["1117017"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1058193"],"award-info":[{"award-number":["1058193"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1113293"],"award-info":[{"award-number":["1113293"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","award":["36239"],"award-info":[{"award-number":["36239"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00262-021-03118-9","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T05:06:51Z","timestamp":1638421611000},"page":"1259-1273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cues"],"prefix":"10.1007","volume":"71","author":[{"given":"Tony","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Rudak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line M.","family":"Laumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex R.","family":"Michaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasheduzzaman","family":"Rashu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha N.","family":"Knier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula J.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamish E. G.","family":"McWilliam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Villadangos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad H.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel E.","family":"DiMattia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor G.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1125-8176","authenticated-orcid":false,"given":"S. M. Mansour","family":"Haeryfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"3118_CR1","doi-asserted-by":"publisher","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","volume":"2","author":"UA Matulonis","year":"2016","unstructured":"Matulonis UA, Sood AK, Fallowfield L et al (2016) Ovarian cancer. Nat Rev Dis Primers 2:16061. https:\/\/doi.org\/10.1038\/nrdp.2016.61","journal-title":"Nat Rev Dis Primers"},{"key":"3118_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejca.2017.10.030","volume":"88","author":"M Timmermans","year":"2018","unstructured":"Timmermans M, Sonke GS, Van de Vijver KK et al (2018) No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands. Eur J Cancer 88:31\u201337. https:\/\/doi.org\/10.1016\/j.ejca.2017.10.030","journal-title":"Eur J Cancer"},{"issue":"1","key":"3118_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/jnci\/djy071","volume":"111","author":"LC Peres","year":"2019","unstructured":"Peres LC, Cushing-Haugen KL, K\u00f6bel M et al (2019) Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage. J Natl Cancer Inst 111(1):60\u201368. https:\/\/doi.org\/10.1093\/jnci\/djy071","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"3118_CR4","first-page":"1663","volume":"32","author":"GB Feldman","year":"1972","unstructured":"Feldman GB, Knapp RC, Order SE et al (1972) The role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma. Cancer Res 32(8):1663\u20131666","journal-title":"Cancer Res"},{"key":"3118_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fonc.2013.00256","volume":"3","author":"N Ahmed","year":"2013","unstructured":"Ahmed N, Stenvers KL (2013) Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research. Front Oncol 3:256. https:\/\/doi.org\/10.3389\/fonc.2013.00256","journal-title":"Front Oncol"},{"issue":"2","key":"3118_CR6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ygyno.2011.09.039","volume":"124","author":"WT Hwang","year":"2012","unstructured":"Hwang WT, Adams SF, Tahirovic E et al (2012) Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis. Gynecol Oncol 124(2):192\u2013198. https:\/\/doi.org\/10.1016\/j.ygyno.2011.09.039","journal-title":"Gynecol Oncol"},{"issue":"4","key":"3118_CR7","first-page":"1553","volume":"34","author":"E Smolle","year":"2014","unstructured":"Smolle E, Taucher V, Haybaeck J (2014) Malignant ascites in ovarian cancer and the role of targeted therapeutics. Anticancer Res 34(4):1553\u20131561","journal-title":"Anticancer Res"},{"issue":"7","key":"3118_CR8","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.ejca.2012.11.037","volume":"49","author":"IF Voutsas","year":"2013","unstructured":"Voutsas IF, Pistamaltzian N, Tsiatas ML et al (2013) Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin \u03b1 or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID mice. Eur J Cancer 49(7):1706\u20131714. https:\/\/doi.org\/10.1016\/j.ejca.2012.11.037","journal-title":"Eur J Cancer"},{"issue":"25","key":"3118_CR9","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1056\/NEJMc1713444","volume":"377","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan M, Hopkins A, Jaffee EM (2017) Tumor Mutational Burden and Response Rate to PD-1 Inhibition. N Engl J Med 377(25):2500\u20132501. https:\/\/doi.org\/10.1056\/NEJMc1713444","journal-title":"N Engl J Med"},{"issue":"7500","key":"3118_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nature13160","volume":"509","author":"AJ Corbett","year":"2014","unstructured":"Corbett AJ, Eckle SB, Birkinshaw RW et al (2014) T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature 509(7500):361\u2013365. https:\/\/doi.org\/10.1038\/nature13160","journal-title":"Nature"},{"issue":"1","key":"3118_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/eji.201343509","volume":"44","author":"JE Ussher","year":"2014","unstructured":"Ussher JE, Bilton M, Attwod E et al (2014) CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner. Eur J Immunol 44(1):195\u2013203. https:\/\/doi.org\/10.1002\/eji.201343509","journal-title":"Eur J Immunol"},{"issue":"4","key":"3118_CR12","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1182\/blood-2010-08-303339","volume":"117","author":"M Dusseaux","year":"2011","unstructured":"Dusseaux M, Martin E, Serriari N et al (2011) Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 117(4):1250\u20131259. https:\/\/doi.org\/10.1182\/blood-2010-08-303339","journal-title":"Blood"},{"issue":"3","key":"3118_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/jlb.4ri0118-023r","volume":"104","author":"PT Rudak","year":"2018","unstructured":"Rudak PT, Choi J, Haeryfar SMM (2018) MAIT cell-mediated cytotoxicity: Roles in host defense and therapeutic potentials in infectious diseases and cancer. J Leukoc Biol 104(3):473\u2013486. https:\/\/doi.org\/10.1002\/jlb.4ri0118-023r","journal-title":"J Leukoc Biol"},{"issue":"12","key":"3118_CR14","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s00262-017-2050-7","volume":"66","author":"CR Shaler","year":"2017","unstructured":"Shaler CR, Tun-Abraham ME, Skaro AI et al (2017) Mucosa-associated invariant T cells infiltrate hepatic metastases in patients with colorectal carcinoma but are rendered dysfunctional within and adjacent to tumor microenvironment. Cancer Immunol Immunother 66(12):1563\u20131575. https:\/\/doi.org\/10.1007\/s00262-017-2050-7","journal-title":"Cancer Immunol Immunother"},{"key":"3118_CR15","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3389\/fimmu.2020.01691","volume":"11","author":"T Yao","year":"2020","unstructured":"Yao T, Shooshtari P, Haeryfar SMM (2020) leveraging public single-cell and bulk transcriptomic datasets to delineate MAIT cell roles and phenotypic characteristics in human malignancies. Front Immunol 11:1691. https:\/\/doi.org\/10.3389\/fimmu.2020.01691","journal-title":"Front Immunol"},{"issue":"4","key":"3118_CR16","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/carcin\/21.4.585","volume":"21","author":"KF Roby","year":"2000","unstructured":"Roby KF, Taylor CC, Sweetwood JP et al (2000) Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis 21(4):585\u2013591. https:\/\/doi.org\/10.1093\/carcin\/21.4.585","journal-title":"Carcinogenesis"},{"issue":"14","key":"3118_CR17","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1158\/1078-0432.ccr-20-4394","volume":"27","author":"CM Laumont","year":"2021","unstructured":"Laumont CM, Wouters MCA, Smazynski J et al (2021) Single-cell profiles and prognostic impact of tumor-infiltrating lymphocytes coexpressing CD39, CD103, and PD-1 in ovarian cancer. Clin Cancer Res 27(14):4089\u20134100. https:\/\/doi.org\/10.1158\/1078-0432.ccr-20-4394","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3118_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41592-019-0654-x","volume":"17","author":"RA Amezquita","year":"2020","unstructured":"Amezquita RA, Lun ATL, Becht E et al (2020) Orchestrating single-cell analysis with bioconductor. Nat Methods 17(2):137\u2013145. https:\/\/doi.org\/10.1038\/s41592-019-0654-x","journal-title":"Nat Methods"},{"issue":"12","key":"3118_CR19","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J et al (2019) Fast, sensitive and accurate integration of single-cell data with harmony. Nat Methods 16(12):1289\u20131296. https:\/\/doi.org\/10.1038\/s41592-019-0619-0","journal-title":"Nat Methods"},{"key":"3118_CR20","doi-asserted-by":"publisher","unstructured":"Borcherding N, Bormann NL, Kraus G (2020) scRepertoire: An R-based toolkit for single-cell immune receptor analysis. F1000Res 9:47. doi:https:\/\/doi.org\/10.12688\/f1000research.22139.2","DOI":"10.12688\/f1000research.22139.2"},{"issue":"12","key":"3118_CR21","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1084\/jem.189.12.1907","volume":"189","author":"F Tilloy","year":"1999","unstructured":"Tilloy F, Treiner E, Park SH et al (1999) An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha\/beta T cell subpopulation in mammals. J Exp Med 189(12):1907\u20131921. https:\/\/doi.org\/10.1084\/jem.189.12.1907","journal-title":"J Exp Med"},{"issue":"1","key":"3118_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.178.1.1","volume":"178","author":"S Porcelli","year":"1993","unstructured":"Porcelli S, Yockey CE, Brenner MB et al (1993) Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha\/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J Exp Med 178(1):1\u201316. https:\/\/doi.org\/10.1084\/jem.178.1.1","journal-title":"J Exp Med"},{"issue":"3","key":"3118_CR23","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1084\/jem.180.3.1097","volume":"180","author":"O Lantz","year":"1994","unstructured":"Lantz O, Bendelac A (1994) An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J Exp Med 180(3):1097\u20131106. https:\/\/doi.org\/10.1084\/jem.180.3.1097","journal-title":"J Exp Med"},{"key":"3118_CR24","doi-asserted-by":"publisher","unstructured":"Hao Y, Hao S, Andersen-Nissen E et al (2020) Integrated analysis of multimodal single-cell data. bioRxiv:2020.2010.2012.335331. doi:https:\/\/doi.org\/10.1101\/2020.10.12.335331","DOI":"10.1101\/2020.10.12.335331"},{"issue":"11","key":"3118_CR25","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1172\/jci82424","volume":"125","author":"Y Cui","year":"2015","unstructured":"Cui Y, Franciszkiewicz K, Mburu YK et al (2015) Mucosal-associated invariant T cell-rich congenic mouse strain allows functional evaluation. J Clin Invest 125(11):4171\u20134185. https:\/\/doi.org\/10.1172\/jci82424","journal-title":"J Clin Invest"},{"issue":"6","key":"3118_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2001930","volume":"15","author":"CR Shaler","year":"2017","unstructured":"Shaler CR, Choi J, Rudak PT et al (2017) MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression. PLoS Biol 15(6):e2001930. https:\/\/doi.org\/10.1371\/journal.pbio.2001930","journal-title":"PLoS Biol"},{"issue":"2","key":"3118_CR27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1182\/blood-2011-05-353789","volume":"119","author":"LJ Walker","year":"2012","unstructured":"Walker LJ, Kang YH, Smith MO et al (2012) Human MAIT and CD8\u03b1\u03b1 cells develop from a pool of type-17 precommitted CD8+ T cells. Blood 119(2):422\u2013433. https:\/\/doi.org\/10.1182\/blood-2011-05-353789","journal-title":"Blood"},{"issue":"6","key":"3118_CR28","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/eji.201646837","volume":"47","author":"D Cibri\u00e1n","year":"2017","unstructured":"Cibri\u00e1n D, S\u00e1nchez-Madrid F (2017) CD69: from activation marker to metabolic gatekeeper. Eur J Immunol 47(6):946\u2013953. https:\/\/doi.org\/10.1002\/eji.201646837","journal-title":"Eur J Immunol"},{"issue":"2","key":"3118_CR29","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1158\/1078-0432.ccr-13-1877","volume":"20","author":"JR Webb","year":"2014","unstructured":"Webb JR, Milne K, Watson P et al (2014) Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer. Clin Cancer Res 20(2):434\u2013444. https:\/\/doi.org\/10.1158\/1078-0432.ccr-13-1877","journal-title":"Clin Cancer Res"},{"issue":"12","key":"3118_CR30","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s00262-018-2132-1","volume":"67","author":"SMM Haeryfar","year":"2018","unstructured":"Haeryfar SMM, Shaler CR, Rudak PT (2018) Mucosa-associated invariant T cells in malignancies: a faithful friend or formidable foe? Cancer Immunol Immunother 67(12):1885\u20131896. https:\/\/doi.org\/10.1007\/s00262-018-2132-1","journal-title":"Cancer Immunol Immunother"},{"issue":"10","key":"3118_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003681","volume":"9","author":"L Le Bourhis","year":"2013","unstructured":"Le Bourhis L, Dusseaux M, Bohineust A et al (2013) MAIT cells detect and efficiently lyse bacterially-infected epithelial cells. PLoS Pathog 9(10):e1003681. https:\/\/doi.org\/10.1371\/journal.ppat.1003681","journal-title":"PLoS Pathog"},{"issue":"8","key":"3118_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005072","volume":"11","author":"E Leeansyah","year":"2015","unstructured":"Leeansyah E, Sv\u00e4rd J, Dias J et al (2015) Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog 11(8):e1005072. https:\/\/doi.org\/10.1371\/journal.ppat.1005072","journal-title":"PLoS Pathog"},{"issue":"2","key":"3118_CR33","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/mi.2014.81","volume":"8","author":"A Kurioka","year":"2015","unstructured":"Kurioka A, Ussher JE, Cosgrove C et al (2015) MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets. Mucosal Immunol 8(2):429\u2013440. https:\/\/doi.org\/10.1038\/mi.2014.81","journal-title":"Mucosal Immunol"},{"issue":"12","key":"3118_CR34","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1016\/j.celrep.2019.08.054","volume":"28","author":"R Lamichhane","year":"2019","unstructured":"Lamichhane R, Schneider M, de la Harpe SM et al (2019) TCR- or Cytokine-Activated CD8(+) Mucosal-Associated Invariant T Cells Are Rapid Polyfunctional Effectors That Can Coordinate Immune Responses. Cell Rep 28(12):3061-3076.e3065. https:\/\/doi.org\/10.1016\/j.celrep.2019.08.054","journal-title":"Cell Rep"},{"issue":"3","key":"3118_CR35","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jhep.2020.03.033","volume":"73","author":"MS Rha","year":"2020","unstructured":"Rha MS, Han JW, Kim JH et al (2020) Human liver CD8(+) MAIT cells exert TCR\/MR1-independent innate-like cytotoxicity in response to IL-15. J Hepatol 73(3):640\u2013650. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.033","journal-title":"J Hepatol"},{"issue":"8","key":"3118_CR36","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.4049\/jimmunol.1700615","volume":"199","author":"M Salio","year":"2017","unstructured":"Salio M, Gasser O, Gonzalez-Lopez C et al (2017) activation of human mucosal-associated invariant T cells induces CD40L-dependent maturation of monocyte-derived and primary dendritic cells. J Immunol 199(8):2631\u20132638. https:\/\/doi.org\/10.4049\/jimmunol.1700615","journal-title":"J Immunol"},{"issue":"5","key":"3118_CR37","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/imcb.12021","volume":"96","author":"NA Gherardin","year":"2018","unstructured":"Gherardin NA, Souter MN, Koay HF et al (2018) Human blood MAIT cell subsets defined using MR1 tetramers. Immunol Cell Biol 96(5):507\u2013525. https:\/\/doi.org\/10.1111\/imcb.12021","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"3118_CR38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1158\/2159-8290.cd-19-0569","volume":"10","author":"J Yan","year":"2020","unstructured":"Yan J, Allen S, McDonald E et al (2020) MAIT cells promote tumor initiation, growth, and metastases via tumor MR1. Cancer Discov 10(1):124\u2013141. https:\/\/doi.org\/10.1158\/2159-8290.cd-19-0569","journal-title":"Cancer Discov"},{"issue":"1","key":"3118_CR39","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1038\/s41467-018-07207-9","volume":"9","author":"B van Wilgenburg","year":"2018","unstructured":"van Wilgenburg B, Loh L, Chen Z et al (2018) MAIT cells contribute to protection against lethal influenza infection in vivo. Nat Commun 9(1):4706. https:\/\/doi.org\/10.1038\/s41467-018-07207-9","journal-title":"Nat Commun"},{"issue":"1","key":"3118_CR40","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1038\/s41467-018-05202-8","volume":"9","author":"H Wang","year":"2018","unstructured":"Wang H, D\u2019Souza C, Lim XY et al (2018) MAIT cells protect against pulmonary legionella longbeachae infection. Nat Commun 9(1):3350. https:\/\/doi.org\/10.1038\/s41467-018-05202-8","journal-title":"Nat Commun"},{"issue":"34","key":"3118_CR41","doi-asserted-by":"publisher","first-page":"E3562","DOI":"10.1073\/pnas.1403424111","volume":"111","author":"M Rei","year":"2014","unstructured":"Rei M, Gon\u00e7alves-Sousa N, Lan\u00e7a T et al (2014) Murine CD27(-) V\u03b36(+) \u03b3\u03b4 T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages. Proc Natl Acad Sci USA 111(34):E3562-3570. https:\/\/doi.org\/10.1073\/pnas.1403424111","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"3118_CR42","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.3892\/ol.2018.9059","volume":"16","author":"H Liao","year":"2018","unstructured":"Liao H, Zhu H, Liu S et al (2018) Expression of V-domain immunoglobulin suppressor of T cell activation is associated with the advanced stage and presence of lymph node metastasis in ovarian cancer. Oncol Lett 16(3):3465\u20133472. https:\/\/doi.org\/10.3892\/ol.2018.9059","journal-title":"Oncol Lett"},{"issue":"6928","key":"3118_CR43","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nature01433","volume":"422","author":"E Treiner","year":"2003","unstructured":"Treiner E, Duban L, Bahram S et al (2003) Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422(6928):164\u2013169. https:\/\/doi.org\/10.1038\/nature01433","journal-title":"Nature"},{"key":"3118_CR44","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140074","author":"T Parrot","year":"2021","unstructured":"Parrot T, Healy K, Boulouis C et al (2021) Expansion of donor-unrestricted MAIT cells with enhanced cytolytic function suitable for TCR-redirection. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.140074","journal-title":"JCI Insight"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-021-03118-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-021-03118-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-021-03118-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T13:15:39Z","timestamp":1650374139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-021-03118-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["3118"],"URL":"https:\/\/doi.org\/10.1007\/s00262-021-03118-9","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,2]]},"assertion":[{"value":"9 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The data arising from this study are available within the article and its supplementary files or from the corresponding author. The materials used in this study are available from the sources indicated or from the corresponding author upon reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Mouse experiments were performed in compliance with Animal Use Protocol 2018\u2013093 approved by the Animal Care Committee of Animal Care and Veterinary Services at Western University. Human specimens were collected and used as per study protocol H07-00463 approved by the University of British Columbia\u2014BC Cancer Research Ethics Board and protocol 3818 approved by the Western University Research Ethics Board for Health Sciences Research Involving Human Subjects.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all patients who participated in this study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}